KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Gilead Sciences (GILD) over the last 16 years, with Q3 2025 value amounting to $2.0 billion.

  • Gilead Sciences' Long-Term Investments changed N/A to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year change of. This contributed to the annual value of $1.2 billion for FY2023, which is 658.63% down from last year.
  • Latest data reveals that Gilead Sciences reported Long-Term Investments of $2.0 billion as of Q3 2025.
  • Gilead Sciences' Long-Term Investments' 5-year high stood at $2.0 billion during Q3 2025, with a 5-year trough of $579.0 million in Q1 2021.
  • In the last 4 years, Gilead Sciences' Long-Term Investments had a median value of $1.3 billion in 2021 and averaged $1.3 billion.
  • Data for Gilead Sciences' Long-Term Investments shows a peak YoY increase of 16075.7% (in 2021) and a maximum YoY decrease of 8359.31% (in 2021) over the last 5 years.
  • Quarter analysis of 4 years shows Gilead Sciences' Long-Term Investments stood at $1.3 billion in 2021, then fell by 4.89% to $1.2 billion in 2022, then fell by 6.59% to $1.2 billion in 2023, then skyrocketed by 72.4% to $2.0 billion in 2025.
  • Its Long-Term Investments stands at $2.0 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.2 billion for Q4 2023.